The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma

Background. The aim of the study was to calculate the short-term and long-term outcomes of curative-intent surgery in distal cholangiocarcinoma (DCC) patients to identify potential prognostic factors. Patients and Methods. A retrospective cohort study of 32 consecutive DCC patients treated with panc...

Full description

Bibliographic Details
Main Authors: Pavel Skalicky, Ondrej Urban, Jiri Ehrmann, Hana Svebisova, Dusan Klos, Jana Tesarikova, Cestmir Neoral, Katerina Knapkova, Martin Lovecek
Format: Article
Language:English
Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2022-12-01
Series:Biomedical Papers
Subjects:
Online Access:https://biomed.papers.upol.cz/artkey/bio-202204-0005_the-short-and-long-term-outcomes-of-pancreaticoduodenectomy-for-distal-cholangiocarcinoma.php
_version_ 1811199214630207488
author Pavel Skalicky
Ondrej Urban
Jiri Ehrmann
Hana Svebisova
Dusan Klos
Jana Tesarikova
Cestmir Neoral
Katerina Knapkova
Martin Lovecek
author_facet Pavel Skalicky
Ondrej Urban
Jiri Ehrmann
Hana Svebisova
Dusan Klos
Jana Tesarikova
Cestmir Neoral
Katerina Knapkova
Martin Lovecek
author_sort Pavel Skalicky
collection DOAJ
description Background. The aim of the study was to calculate the short-term and long-term outcomes of curative-intent surgery in distal cholangiocarcinoma (DCC) patients to identify potential prognostic factors. Patients and Methods. A retrospective cohort study of 32 consecutive DCC patients treated with pancreaticoduodenectomy between 2009-2017. The clinicopathological and histopathological data were evaluated for prognostic factors using the univariable Cox regression analysis. The Overall Survival (OS) was estimated using the Kaplan-Meier analysis. Results. The study comprised a total of 32 patients, with a mean age of 65.8 (± 9.0) years at the time of surgery. R0 resection was achieved in 25 (86.2%) patients, 19 (65.5%) patients received adjuvant oncological therapy. The OS rates at 1, 3 and 5 years were 62.5%, 37.5% and 21.9%, respectively. The 90-day mortality was 3/32 (9.4%) accounting for one-fourth of the first-year mortality rate. The median OS was 28.5 months. The only statistically significant prognostic factor was vascular resection, which was associated with worse OS in the univariable analysis (HR: 3.644; 95%-CI: 1.179-11.216, P=0.025). An age less than 65 years, ASA grade I/II, hospital stay of fewer than 15 days, R0 resection, lymph node ratio less than 0.2 and adjuvant oncological therapy tended to be associated with better OS but without statistically significant relevance. Conclusion. The main factor directly influencing the survival of DCC patients is surgical complications. Surgical mortality comprises a significant group of patients, who die in the first year following pancreaticoduodenectomy. Vascular resection is the most important negative prognostic factor for long-term survival.
first_indexed 2024-04-12T01:44:16Z
format Article
id doaj.art-b340574b087048e38c4ef288dbaa1a4c
institution Directory Open Access Journal
issn 1213-8118
1804-7521
language English
last_indexed 2024-04-12T01:44:16Z
publishDate 2022-12-01
publisher Palacký University Olomouc, Faculty of Medicine and Dentistry
record_format Article
series Biomedical Papers
spelling doaj.art-b340574b087048e38c4ef288dbaa1a4c2022-12-22T03:53:07ZengPalacký University Olomouc, Faculty of Medicine and DentistryBiomedical Papers1213-81181804-75212022-12-01166438639210.5507/bp.2021.043bio-202204-0005The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinomaPavel Skalicky0Ondrej Urban1Jiri Ehrmann2Hana Svebisova3Dusan Klos4Jana Tesarikova5Cestmir Neoral6Katerina Knapkova7Martin Lovecek8Department of Surgery I, University Hospital Olomouc, Czech RepublicDepartment of Internal Medicine II - Gastroenterology and Geriatrics, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech RepublicDepartment of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech RepublicDepartment of Oncology, University Hospital Olomouc, Czech RepublicDepartment of Surgery I, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech RepublicDepartment of Surgery I, University Hospital Olomouc, Czech RepublicDepartment of Surgery I, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech RepublicDepartment of Surgery I, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech RepublicDepartment of Surgery I, University Hospital Olomouc, Czech RepublicBackground. The aim of the study was to calculate the short-term and long-term outcomes of curative-intent surgery in distal cholangiocarcinoma (DCC) patients to identify potential prognostic factors. Patients and Methods. A retrospective cohort study of 32 consecutive DCC patients treated with pancreaticoduodenectomy between 2009-2017. The clinicopathological and histopathological data were evaluated for prognostic factors using the univariable Cox regression analysis. The Overall Survival (OS) was estimated using the Kaplan-Meier analysis. Results. The study comprised a total of 32 patients, with a mean age of 65.8 (± 9.0) years at the time of surgery. R0 resection was achieved in 25 (86.2%) patients, 19 (65.5%) patients received adjuvant oncological therapy. The OS rates at 1, 3 and 5 years were 62.5%, 37.5% and 21.9%, respectively. The 90-day mortality was 3/32 (9.4%) accounting for one-fourth of the first-year mortality rate. The median OS was 28.5 months. The only statistically significant prognostic factor was vascular resection, which was associated with worse OS in the univariable analysis (HR: 3.644; 95%-CI: 1.179-11.216, P=0.025). An age less than 65 years, ASA grade I/II, hospital stay of fewer than 15 days, R0 resection, lymph node ratio less than 0.2 and adjuvant oncological therapy tended to be associated with better OS but without statistically significant relevance. Conclusion. The main factor directly influencing the survival of DCC patients is surgical complications. Surgical mortality comprises a significant group of patients, who die in the first year following pancreaticoduodenectomy. Vascular resection is the most important negative prognostic factor for long-term survival.https://biomed.papers.upol.cz/artkey/bio-202204-0005_the-short-and-long-term-outcomes-of-pancreaticoduodenectomy-for-distal-cholangiocarcinoma.phpcholangiocarcinomapancreaticoduodenectomylong-term survivalprognostic factor
spellingShingle Pavel Skalicky
Ondrej Urban
Jiri Ehrmann
Hana Svebisova
Dusan Klos
Jana Tesarikova
Cestmir Neoral
Katerina Knapkova
Martin Lovecek
The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma
Biomedical Papers
cholangiocarcinoma
pancreaticoduodenectomy
long-term survival
prognostic factor
title The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma
title_full The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma
title_fullStr The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma
title_full_unstemmed The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma
title_short The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma
title_sort short and long term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma
topic cholangiocarcinoma
pancreaticoduodenectomy
long-term survival
prognostic factor
url https://biomed.papers.upol.cz/artkey/bio-202204-0005_the-short-and-long-term-outcomes-of-pancreaticoduodenectomy-for-distal-cholangiocarcinoma.php
work_keys_str_mv AT pavelskalicky theshortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT ondrejurban theshortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT jiriehrmann theshortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT hanasvebisova theshortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT dusanklos theshortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT janatesarikova theshortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT cestmirneoral theshortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT katerinaknapkova theshortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT martinlovecek theshortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT pavelskalicky shortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT ondrejurban shortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT jiriehrmann shortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT hanasvebisova shortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT dusanklos shortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT janatesarikova shortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT cestmirneoral shortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT katerinaknapkova shortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma
AT martinlovecek shortandlongtermoutcomesofpancreaticoduodenectomyfordistalcholangiocarcinoma